Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer	Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)	Recruiting	Phase 3	2026-08-13		NCT07251582

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hunan Province Tumor Hospital	27

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hunan Cancer Hospital	Changsha	China	87
Hunna Cancer Hospital, Clinical Trails Center	Changsha	China	1

Clinical trials